Rare diseases
Investigational molecules
Locations
Study on Omalizumab and Mepolizumab for Patients with Severe Allergic and Eosinophilic Asthma
FranceStudy of rituximab and belimumab combination compared to rituximab alone in adults with persistent or chronic immune thrombocytopenia (ITP)
FranceStudy of gemtuzumab ozogamicin and chemotherapy combinations in children with newly diagnosed acute myeloid leukemia, high-risk myelodysplastic syndrome, or myeloid sarcoma
FranceStudy of Atezolizumab, Carboplatin, and Paclitaxel for Elderly Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy of Azenosertib and Niraparib for Patients with Platinum-Resistant Ovarian Cancer
FranceStudy of Isatuximab for Patients with Type I Cryoglobulinemia
FranceStudy Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy
FranceStudy on the Safety and Effectiveness of Domvanalimab, Zimberelimab, and Quemliclustat in Adults with Advanced Upper Gastrointestinal Cancer
FranceStudy of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate
FranceStudy Comparing Anitocabtagene Autoleucel with Standard Treatment for Patients with Relapsed or Refractory Multiple Myeloma
FranceStudy of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease
FranceStudy on Tezepelumab for Patients with Severe Asthma
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
